Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at

SKU: 299. Category: .

Product Description

FDA Acts to Strengthen the Safety Program for Marketed Drugs

What’s Your Opinion?
Rising Tide of Negative Perception
Ed Wise, President and CEO, Cline, Davis & Mann

Experts Featured in This Section
Michael Astrue
, Transkaryotic Therapies Inc.
Dr. Geert Cauwenbergh, Barrier Therapeutics Inc.
Dr. Brad Thompson, Oncolytics Biotech Inc.
Michael Wilhelm, ImmuneRegen BioSciences Inc.
Dr. Jerome Zeldis, Celgene Corp.